The comparison of albumin and 6% hydroxyethyl starches (130/0.4) in cardiac surgery: a meta-analysis of randomized controlled clinical trials
Abstract Background Fluid administration is a key tool in the maintenance of normovolemia in patients with cardiac surgery. The trials that evaluated the safety of 6% hydroxyethyl starch (HES) 130/0.4 in cardiac surgical patients were inconsistent. It is necessary to compare the efficacy and safety...
Main Authors: | Ling Wei, Dongping Li, Lin Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-09-01
|
Series: | BMC Surgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12893-021-01340-x |
Similar Items
-
Acid/base alterations during major abdominal surgery: 6% hydroxyethyl starch infusion versus 5% albumin
by: Hyun Jeong Kwak, et al.
Published: (2018-12-01) -
Assessment of coagulation with 6% hydroxyethyl starch 130/0.4 in cesarean section
by: Chung-Sik Oh, et al.
Published: (2012-04-01) -
Comparison of Hydroxyethyl starch 130/0.4 (6%) with commonly used agents in an experimental Pleurodesis model
by: Hasan Oğuz Kapicibasi, et al.
Published: (2020-08-01) -
Comparing the Effects of Hydroxyethyl Starch and Albumin in Cirrhotic Patients with Tense Ascites; a Randomized Clinical Trial
by: Alireza Abootalebi, et al.
Published: (2017-10-01) -
Thromboelastometric assessment of hemostasis following hydroxyethyl starch (130/0.4) administration as a constant rate infusion in hypoalbuminemic dogs
by: Angelica Botto, et al.
Published: (2018-01-01)